Invention Grant
- Patent Title: Heteroaryl linked quinolinyl modulators of RORgammat
- Patent Title (中): RORgammat的杂芳基连接的喹啉基调节剂
-
Application No.: US14053736Application Date: 2013-10-15
-
Publication No.: US09328095B2Publication Date: 2016-05-03
- Inventor: Kristi A. Leonard , Kent Barbay , James P. Edwards , Kevin D. Kreutter , David A. Kummer , Umar Maharoof , Rachel Nishimura , Maud Urbanski , Hariharan Venkatesan , Aihua Wang , Ronald L. Wolin , Craig R. Woods , Maxwell D. Cummings
- Applicant: Janssen Pharmaceutica NV
- Assignee: JANSSEN PHARMACEUTICA NV
- Current Assignee: JANSSEN PHARMACEUTICA NV
- Agent Yuriy P. Stercho
- Main IPC: A61K45/06
- IPC: A61K45/06 ; C07D401/14 ; C07D401/12 ; A61K31/4709
Abstract:
The present invention comprises compounds of Formula I. wherein: R1, R2, R3, R4, R5, R6, R7 R8, and R9 are defined in the specification. The invention also comprises a method of treating or ameliorating a syndrome, disorder or disease, wherein said syndrome, disorder or disease is rheumatoid arthritis or psoriasis. The invention also comprises a method of modulating RORγt activity in a mammal by administration of a therapeutically effective amount of at least one compound of claim 1.
Public/Granted literature
- US20150105365A1 HETEROARYL LINKED QUINOLINYL MODULATORS OF RORgammat Public/Granted day:2015-04-16
Information query
